The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Maalox 200mg/175mg per 5ml Oral Suspension



Opella Healthcare France SAS T/A SanofiPA23180/009/001

Main Information

Trade NameMaalox 200mg/175mg per 5ml Oral Suspension
Active SubstancesMagnesium hydroxide
Aluminium hydroxide
Dosage FormOral suspension
Licence HolderOpella Healthcare France SAS T/A Sanofi
Licence NumberPA23180/009/001

Group Information

ATC CodeA02AD Combinations and complexes of aluminium, calcium and magnesium compounds
A02AD01 ordinary salt combinations

Status

Authorised/WithdrawnAuthorised
Licence Issued19/04/1982
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to the general public
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back